Hims & Hers Launches Copy of Wegovy Pill, Prompting Legal Threats

(MedPage Today) — Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill semaglutide (Wegovy), just weeks after drugmaker Novo Nordisk launched its highly anticipated reformulation…

Source link : https://www.medpagetoday.com/endocrinology/obesity/119758

Author :

Publish date : 2026-02-05 20:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Hims & Hers Launches Copy of Wegovy Pill, Prompting Legal Threats

Next-Generation Factor XIa Cuts Recurrent Stroke Risk by 26%

Study Supports Personalized Surveillance for Colon Polyp Recurrence Risk

Related Posts

Most Papers Published in Guest-Edited BMJ Journal Retracted

Dr Chris asks: ‘Why do so many of us have problems with our feet?’

One Intrawound Antibiotic Wins for Surgical Infections After Tibial Fracture Surgery

Robert F. Influencer Jr. Is Selling Politics, Not Health

FDA to Weigh Easing Limits on Unproven Peptides Favored by RFK Jr.

Six ‘Superretractors’ Responsible for Large Number of Retracted Clinical Trials

Most Papers Published in Guest-Edited BMJ Journal Retracted

Dr Chris asks: ‘Why do so many of us have problems with our feet?’

One Intrawound Antibiotic Wins for Surgical Infections After Tibial Fracture Surgery

Robert F. Influencer Jr. Is Selling Politics, Not Health

FDA to Weigh Easing Limits on Unproven Peptides Favored by RFK Jr.

Six ‘Superretractors’ Responsible for Large Number of Retracted Clinical Trials

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

Streeting Pledges Faster Cuts to Gynaecology Waits

Categories

Archives